APA (7th ed.) Citation

JS, N., AR, L., C, V., P, M., F, V., A, L., & JP, F. (2026). Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: A post hoc analysis of the SURPASS-2 Trial. Diabetologia, 69(5), 1216. https://doi.org/10.1007/s00125-025-06637-7

Chicago Style (17th ed.) Citation

JS, Neves, Leite AR, Vale C, Marques P, Vasques-Nóvoa F, Leite-Moreira A, and Ferreira JP. "Efficacy of Tirzepatide Versus Semaglutide in Achieving Therapeutic Targets in Type 2 Diabetes: A Post Hoc Analysis of the SURPASS-2 Trial." Diabetologia 69, no. 5 (2026): 1216. https://doi.org/10.1007/s00125-025-06637-7.

MLA (9th ed.) Citation

JS, Neves, et al. "Efficacy of Tirzepatide Versus Semaglutide in Achieving Therapeutic Targets in Type 2 Diabetes: A Post Hoc Analysis of the SURPASS-2 Trial." Diabetologia, vol. 69, no. 5, 2026, p. 1216, https://doi.org/10.1007/s00125-025-06637-7.